SEC Form 4 · accession 0001209191-15-065547
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Mandell
Director
Period of report
Aug 10, 2015
Accepted (ET)
Aug 12, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2015 | M | 1,500 | $21.43 | A | 1,500 | D | |
| Common StockF2 | Aug 10, 2015 | S | 626 | $146.8308 | D | 874 | D | |
| Common StockF3 | Aug 10, 2015 | S | 299 | $147.8835 | D | 575 | D | |
| Common StockF4 | Aug 10, 2015 | S | 194 | $148.7503 | D | 381 | D | |
| Common StockF5 | Aug 10, 2015 | S | 164 | $150.2816 | D | 217 | D | |
| Common StockF6 | Aug 10, 2015 | S | 127 | $151.7102 | D | 90 | D | |
| Common StockF7 | Aug 10, 2015 | S | 90 | $152.8644 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $21.43 | Aug 10, 2015 | M | 1,500 | A | — | Jan 8, 2024 | Common Stock | 1,500 | 18,500 | D |
Explanation of responses
- F1This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on July 8, 2015.
- F2The range in prices for the transaction reported on this line was $146.34 to 147.31. The average weighted price was $146.8308. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $147.45 to $148.25. The average weighted price was $147.8835. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $148.66 to $149.49. The average weighted price was $148.7503. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $149.81 to $150.81. The average weighted price was $150.2816. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range in prices for the transaction reported on this line was $151.38 to $152.36. The average weighted price was $151.7102. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range in prices for the transaction reported on this line was $152.61 to $153.00. The average weighted price was $152.8644. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8This option vests ratably over three years in annual installments, commencing on January 8, 2014.